SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synthetic Blood (SYBD)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Hoffmann who wrote (268)4/25/1999 9:46:00 PM
From: Micro-Selector  Read Replies (1) of 307
 
Thanks for the clarification.

I assume an "insider" includes only current employees and therefore Araminta Wade, as a "former employee," would not qualify? Was A. Wade an employee at the time of sale?

When R. Nicora reported that these were not "true insiders," I assumed that many of the "planned sales" must have been made by former employees affiliated with or loyal to the previous CEO and that some degree of turnover and insider sell-off had resulted from his resignation. Is this completely off base?

Any opinion on the long-term prospects for SYBD or the pending funding?

Thanks,
Micro
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News